Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep28 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

The relationship between continuous glucose monitoring metrics, circadian rhythms, and the presence of albuminuria in insulin-using patients with type 2 diabetes

Young Lee Da , Lee Jung-Been , Jung Inha , Young Park So , Hee Yu Ji , A Seo Ji , Lee Heon-Jeong , Hee Kim Nan

Background: We aimed to explore the relationship between continuous glucose monitoring (CGM)-derived indicators and the presence of albuminuria taking circadian features into consideration concurrently in Insulin-using patients with type 2 diabetes.Methods: We analyzed data from 129 insulin-treated type 2 diabetes patients in Korea University Ansan Hospital. Over 10 days, we collected time-series data using Dexcom G6, Fitbit, and food diaries, along with...

ea0090p720 | Reproductive and Developmental Endocrinology | ECE2023

Endocrine and Non-Endocrine Causes of Fatigue in Adults With Turner Syndrome: Cohort Study and Review of the Literature

Rosenberg Anna , Dingemans Veerle D.A. , Roubos Anja , Luijks Sanne , Dessens Arianne B. , Dykgraaf Ramon , Roos-Hesselink Jolien W. , van Rossum Elisabeth , Jan van der Lely Aart , De Graaff Laura

Background: Turner syndrome (TS) is a rare genetic developmental disorder characterized by gonadal dysfunction, short stature and heart defects, among others. Women with TS often suffer from severe fatigue, for which they are typically referred to endocrinologists. The diagnostic work-up is generally time-consuming and invasive, but it rarely solves the problem. To prevent the personal and financial burden of unnecessary diagnostic procedures, it is crucial to understand fatig...

ea0065p235 | Metabolism and Obesity | SFEBES2019

Insights into the mechanisms underpinning the physiological effects of biased GLP-1 receptor agonists

Lucey Maria , Pickford Phil , Ma Yue , Shchepinova Maria , Tate Ed , McGinty James , French Paul , Davies Samuel , Xavier Gabriela Da Silva , Stolarczyk Emilie , Minnion James , Rutter Guy , Bloom Steve , Tomas Alejandra , Jones Ben

Glucagon-like peptide-1 receptor (GLP-1R) agonists are effective treatments for type 2 diabetes and obesity. We recently described ‘biased’ peptide GLP-1R agonists modelled on exendin-4 which uncouple the pronounced endocytosis that usually accompanies GLP-1R activation, leading to prolongation of intracellular signalling responses. Here, we show that the metabolic consequences of biased GLP-1R activation in vivo are dominated by improvements in blood glucos...

ea0063gp202 | Diabetes: Pharmacotherapy | ECE2019

The growth hormone effect blocked with pegvisomant did not alter the free fat acid plasma concentration in pre-diebetic or type 2 diabetic patients treated with empagliflozin

da Rocha Aline Franco , Junior Paulo Sergio Pereira , Calefi Gabriela Simonetti , Morimoto Helena Kaminami , Marquezine Guilherme Figueiredo , Mazzuco Tania Longo , de Faria Eliana Cotta , Urbano Mariana Ragassi , Carrilho Alexandre Jose Faria

Context: Sodium-glucose cotransporter 2 (SGLT2) inhibitors induce glycosuria and improve glycemic control, β cell function and insulin sensitivity in type 2 diabetes mellitus (DM2). On the other hand, these drugs predispose to diabetic ketoacidosis by increasing the tonus of glucagon. Glucagon acts on the liver and has no relevant effect on peripheral lipolysis and release of free fatty acids (FFA) as a substrate for ketogenesis, an action attributed to growth hormone (GH...

ea0063p155 | Diabetes, Obesity and Metabolism 1 | ECE2019

Improvement of human pancreatic islet quality after co-culture with human adipose-derived stem cells

de Souza Bianca , Rodrigues Michelle , de Oliveira Fernanda , da Silva Liana , Boucas Ana Paula , Portinho Ciro , dos Santos Bruno , Camassola Melissa , Martini Juliano , Leitao Cristiane , Nardi Nance , Bauer Andrea Carla , Crispim Daisy

Introduction: Pancreatic islet transplantation is an effective treatment for patients with type 1 diabetes mellitus (T1DM) with unstable metabolic control. However, the quality of islets isolated from a donor is negatively affected by the inflammatory environment related to the donor’s brain death and by the stress related to islet isolation and culture. To overcome islet quality loss, some studies have co-cultured islets with mesenchymal stromal cells (MSCs). Considering...

ea0049oc14.3 | Thyroid Cancer | ECE2017

TERT, BRAF and NRAS in the molecular profile of metastatic thyroid cancer: differences between primary and distant disease

Melo Miguel , Gaspar da Rocha Adriana , Batista Rui , Vinagre Joao , Joao Martins Maria , Costa Gracinda , Ribeiro Cristina , Carrilho Francisco , Leite Valeriano , Lobo Claudia , Manuel Cameselle-Teijeiro Jose , Sobrinho-Simoes Manuel , Soares Paula

Context: Little is known about the frequency of key mutations in thyroid cancer metastases and its relationship with the primary tumor genotype.Objectives: To evaluate the frequency of TERT promoter (TERTp), BRAF and NRAS mutations in metastatic thyroid carcinomas, analyzing primary thyroid tumors, lymph node metastases (LNM) and distant metastases.Material and Methods: Mutation analysis was performed in 437 tissue samples from 204...

ea0049ep1422 | Thyroid (non-cancer) | ECE2017

Incidental thyroid uptake detected by 68Ga-DOTANOC positron Emission Tomography: is it clinical significant?

Silva Tiago Nunes da , Santos Joaquim Gomes , Matos Ana Catarina , Teixeira Joao Pedro , Oliveira Carla , Castanheira Joana , Carmona Susana , Duarte Hugo , Costa Durval , Oliveira Luis , Santos Ana Isabel , Portugal Jorge

Background: The detection of thyroid incidental uptake of radiopharmaceuticals has been increasing. Those detected by 18F-fluorodeoxyglucose positron emission tomography (PET) have been associated with a significant risk of malignancy (8–64%). Gallium-68 (Ga-68) labelled peptides are now the standard imaging modality for staging neuroendocrine tumours (NET). Its high sensitivity has increased the discovery of incidental findings. The aim of this study was to ev...

ea0049ep1449 | Thyroid (non-cancer) | ECE2017

The usefulness of the study of sodium iodide symporter expression in thyroid primary tumors

Tavares Catarina , Coelho Maria Joao , Eloy Catarina , Melo Miguel , da Rocha Adriana Gaspar , Pestana Ana , Batista Rui , Ferreira Luciana Bueno , Rios Elisabete , Cavadas Bruno , Pereira Luisa , Selmi-Ruby Samia , Simoes Manuel Sobrinho , Soares Paula

Thyroid cancer therapy is based on surgery followed by radioiodine treatment of tumor remnants and metastases. The incorporation of radioiodine by cancer cells is mediated by sodium iodide symporter (NIS), normally present in thyroid follicular cells’ membrane. We studied the expression of NIS in a series of 229 thyroid primary tumors using real time PCR and immunohistochemistry, and searched for possible associations between NIS expression and clinicopathological feature...

ea0070oc7.3 | Endocrine-related Cancer | ECE2020

Sterol O-Acyl transferase 1 as a prognostic marker of adrenocortical carcinoma

Ferreira Lacombe Amanda M , Cauduro Soares Ibere , Bezerra-Neto João Evangelista , da Silva Charchar Helaine , Hoff Ana O , Almeida Madson Q , Weigand Isabel , Kroiss Matthias , Nogueira Zerbini Maria Claudia , Barisson Villares Fragoso Maria Candida

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with an unfavorable prognosis. Despite the poor prognosis in the majority of patients, no improvements in treatment strategies have been achieved. Therefore, the discovery of new prognostic biomarkers is of enormous interest. Sterol-O-acyl transferase 1 (SOAT1) is involved in cholesterol esterification and lipid droplet formation. Recently, it was demonstrated that SOAT1 inhibition leads to impaired steroidogenesis ...

ea0029n5 | (1) | ICEECE2012

Translation and cultural adaptation of the Brazilian version of patient assessment of chronic illness care: Pacic-Brazil

Landim Camila Aparecida Pinheiro , Almeida Fabio Araujo De , Xavier Antonia Tayana Da Franca , De Andrade Thiago Antonio Moretti , Zanetti Maria Lucia , Martins Maria Manuela , Paul Constanca , Teixeira Carla Regina De Souza

Background: The Chronic Care Model (CCM), developed by Wagner et al., at MacColl Institute for Heathcare Innovation at Group Health Research Institute, Seattle, Washington, United States, is one approach to improving chronic illness care, including diabetes mellitus (DM), that is being used increasingly to assess and improve care. The CCM is based on evidence-based practices and reviews of the literature on effective care. The Patient Assessment of Chronic Illnes...